CLARITIN(R) (loratadine) Celebrates Eight Years of Convenient Seasonal Allergy Relief in the U.S.

- Over 10 Billion Patient Days Worldwide -



Apr 16, 2001, 01:00 ET from Schering Laboratories

    KENILWORTH, N.J., April 16 /PRNewswire/ -- CLARITIN(R) (loratadine), the
 nation's #1 prescribed antihistamine, today celebrates its eighth year of
 providing convenient, safe and effective allergy relief to seasonal allergy
 sufferers in the United States.*  CLARITIN(R) offers an excellent safety
 profile without inconvenient dosing restrictions and is nonsedating when taken
 at the recommended dose.  Seasonal allergy sufferers can take CLARITIN(R)
 without regard to meals (i.e. with a full or empty stomach).  In addition,
 CLARITIN(R) offers the widest range of nonsedating antihistamine formulations.
     "CLARITIN(R) is a versatile, convenient medication for the treatment of
 seasonal allergy symptoms," said Dr. Eric Schenkel of the Valley Clinical
 Research Center in Easton, Pennsylvania, referring to the medication's
 easy-to-use profile.  CLARITIN(R) can be safely co-administered with the
 antibiotic erythromycin, the antifungal ketokonazole and the heartburn
 medication cimetidine.  CLARITIN(R) Tablets, with its once daily dosing, can
 be taken at any time of the day.
     Experts are predicting higher levels of pollen in some sections of the
 country, including New Jersey, Kansas, and Colorado, this spring, which could
 mean a more difficult allergy season for area residents.  According to
 Surveillance Data Inc. (SDI), a national pollen-reporting agency, other areas
 throughout the nation will experience pollen levels as severe as those of last
 spring.  "Allergy sufferers should not wait until the height of spring allergy
 season to think about treatment options for allergy symptoms," Dr. Schenkel
 said.
     The CLARITIN(R) (loratadine) brand has been on the world market since 1988
 and became available in the United States in April of 1993.
 
     About CLARITIN(R)
     The CLARITIN(R) franchise has over 10 billion days of patient experience
 worldwide.(1)  Taken once a day at the recommended dose as directed by a
 physician, CLARITIN(R) has been shown to alleviate seasonal allergy symptoms
 including sneezing, runny nose, and itchy and watery eyes, without causing
 drowsiness.
     The most common side effects with CLARITIN(R) Tablets occurred about as
 often as they did with a sugar pill, including headache, drowsiness, fatigue,
 and dry mouth.
     Please see accompanying additional important information:
 http://www.claritin.com/view_pi/pi_clar.html?id=2553700
     The CLARITIN(R) Family of Products offers allergy patients nonsedating
 symptom relief in a variety of convenient dosage forms.  For more information
 about the CLARITIN(R) Family of Products, log on to http://www.claritin.com or
 call 1-800-CLARITIN.
 
     About Schering Laboratories
     Schering Laboratories is the U.S. prescription pharmaceutical marketing
 arm of Schering-Plough Corporation (NYSE:   SGP) of Kenilworth, N.J., a
 research-based company engaged in the discovery, development, manufacturing,
 and marketing of pharmaceutical products worldwide.
 
     *   These findings are based on a total written prescription comparison of
         loratadine with other leading antihistamines.
         IMS National Prescription Audit Plus. September 1994 to
         present (1/01).
 
     (1) Based on the CLARITIN (R) Family of Products.
 
 

SOURCE Schering Laboratories
    KENILWORTH, N.J., April 16 /PRNewswire/ -- CLARITIN(R) (loratadine), the
 nation's #1 prescribed antihistamine, today celebrates its eighth year of
 providing convenient, safe and effective allergy relief to seasonal allergy
 sufferers in the United States.*  CLARITIN(R) offers an excellent safety
 profile without inconvenient dosing restrictions and is nonsedating when taken
 at the recommended dose.  Seasonal allergy sufferers can take CLARITIN(R)
 without regard to meals (i.e. with a full or empty stomach).  In addition,
 CLARITIN(R) offers the widest range of nonsedating antihistamine formulations.
     "CLARITIN(R) is a versatile, convenient medication for the treatment of
 seasonal allergy symptoms," said Dr. Eric Schenkel of the Valley Clinical
 Research Center in Easton, Pennsylvania, referring to the medication's
 easy-to-use profile.  CLARITIN(R) can be safely co-administered with the
 antibiotic erythromycin, the antifungal ketokonazole and the heartburn
 medication cimetidine.  CLARITIN(R) Tablets, with its once daily dosing, can
 be taken at any time of the day.
     Experts are predicting higher levels of pollen in some sections of the
 country, including New Jersey, Kansas, and Colorado, this spring, which could
 mean a more difficult allergy season for area residents.  According to
 Surveillance Data Inc. (SDI), a national pollen-reporting agency, other areas
 throughout the nation will experience pollen levels as severe as those of last
 spring.  "Allergy sufferers should not wait until the height of spring allergy
 season to think about treatment options for allergy symptoms," Dr. Schenkel
 said.
     The CLARITIN(R) (loratadine) brand has been on the world market since 1988
 and became available in the United States in April of 1993.
 
     About CLARITIN(R)
     The CLARITIN(R) franchise has over 10 billion days of patient experience
 worldwide.(1)  Taken once a day at the recommended dose as directed by a
 physician, CLARITIN(R) has been shown to alleviate seasonal allergy symptoms
 including sneezing, runny nose, and itchy and watery eyes, without causing
 drowsiness.
     The most common side effects with CLARITIN(R) Tablets occurred about as
 often as they did with a sugar pill, including headache, drowsiness, fatigue,
 and dry mouth.
     Please see accompanying additional important information:
 http://www.claritin.com/view_pi/pi_clar.html?id=2553700
     The CLARITIN(R) Family of Products offers allergy patients nonsedating
 symptom relief in a variety of convenient dosage forms.  For more information
 about the CLARITIN(R) Family of Products, log on to http://www.claritin.com or
 call 1-800-CLARITIN.
 
     About Schering Laboratories
     Schering Laboratories is the U.S. prescription pharmaceutical marketing
 arm of Schering-Plough Corporation (NYSE:   SGP) of Kenilworth, N.J., a
 research-based company engaged in the discovery, development, manufacturing,
 and marketing of pharmaceutical products worldwide.
 
     *   These findings are based on a total written prescription comparison of
         loratadine with other leading antihistamines.
         IMS National Prescription Audit Plus. September 1994 to
         present (1/01).
 
     (1) Based on the CLARITIN (R) Family of Products.
 
 SOURCE  Schering Laboratories

RELATED LINKS

http://www.sch-plough.com